Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$12.36 - $18.28 $6,921 - $10,236
-560 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$17.11 - $24.49 $85 - $122
5 Added 0.9%
560 $9,000
Q2 2021

Aug 12, 2021

BUY
$23.12 - $29.91 $578 - $747
25 Added 4.72%
555 $13,000
Q1 2021

May 13, 2021

BUY
$14.69 - $42.57 $1,762 - $5,108
120 Added 29.27%
530 $13,000
Q4 2020

Feb 12, 2021

BUY
$12.88 - $19.47 $5,280 - $7,982
410 New
410 $7,000

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $217M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.